Synthesis and evaluation of the anticonvulsant activity of 8-alkoxy-4,5-dihydrobenzo[b][1,2,4]triazolo[4,3-d][1,4]thiazepine derivatives
暂无分享,去创建一个
[1] J. Sirven,et al. Antiepileptic drugs 2012: recent advances and trends. , 2012, Mayo Clinic proceedings.
[2] Ming-Xia Song,et al. Synthesis and Anticonvulsant Activities of Some Triazolothiadiazole Derivatives , 2012, Archiv der Pharmazie.
[3] N. Patel,et al. Antimycobacterial and antimicrobial study of new 1,2,4‐triazoles with benzothiazoles , 2010, Archiv der Pharmazie.
[4] Ming-Xia Song,et al. Synthesis and anticonvulsant activity of 7-alkoxy-triazolo-[3, 4-b]benzo[d]thiazoles. , 2010, Medicinal chemistry (Shariqah (United Arab Emirates)).
[5] Xianqing Deng,et al. Design and synthesis of 10-alkoxy-5, 6-dihydro-triazolo[4,3-d]benzo[f][1,4]oxazepine derivatives with anticonvulsant activity. , 2010, European journal of medicinal chemistry.
[6] S. Verma,et al. Synthesis, anticonvulsant and toxicity screening of newer pyrimidine semicarbazone derivatives. , 2010, European journal of medicinal chemistry.
[7] J. Stables,et al. Synthesis, anticonvulsant and antimicrobial activities of some new 2-acetylnaphthalene derivatives. , 2010, Bioorganic & medicinal chemistry.
[8] Xianqing Deng,et al. Synthesis and anticonvulsant activity of some 7-alkoxy-2H-1,4-benzothiazin-3(4H)-ones and 7-alkoxy-4H-[1,2,4]triazolo[4,3-d]benzo[b][1,4]thiazines. , 2010, Chemical & pharmaceutical bulletin.
[9] A. Demirbaş,et al. Synthesis of some new 1,2,4-triazoles starting from isonicotinic acid hydrazide and evaluation of their antimicrobial activities. , 2009, European journal of medicinal chemistry.
[10] A. V. Adhikari,et al. Synthesis and antimicrobial activities of novel quinoline derivatives carrying 1,2,4-triazole moiety. , 2009, European journal of medicinal chemistry.
[11] P. Penovich,et al. Use of a new antiepileptic drug or an old one as first drug for treatment of absence epilepsy , 2009, Epilepsia.
[12] A. Aldenkamp,et al. The impact of side effects on long-term retention in three new antiepileptic drugs , 2009, Seizure.
[13] V. P. Vaidya,et al. Studies on Synthesis and Pharmacological Activities of 1,2,4‐Triazolo[3,4‐b]1,3,4‐thiadiazoles and their Dihydro Analogues , 2009, Archiv der Pharmazie.
[14] K. Chai,et al. Synthesis and Anticonvulsant Activity of 6‐Alkoxy‐[1,2,4]Triazolo[3,4‐a]Phthalazines , 2009, Chemical biology & drug design.
[15] Li-Ming Zhao,et al. Design and synthesis of 5-alkoxy-[1,2,4]triazolo[4,3-a]quinoline derivatives with anticonvulsant activity. , 2009, European journal of medicinal chemistry.
[16] R. Loddo,et al. In‐Vitro Anti‐HIV and Antitumor Activity of New 3,6‐Disubstituted [1,2,4]Triazolo[3,4‐b][1,3,4]thiadiazoles and Thiadiazine Analogues , 2008, Archiv der Pharmazie.
[17] Y. Al-Soud. Synthesis and anti‐HIV Activity of Substituted 1,2,4‐Triazolo‐thiophene Derivatives. , 2007 .
[18] René H. Levy,et al. Progress report on new antiepileptic drugs: A summary of the Eigth Eilat Conference (EILAT VIII) , 2007, Epilepsy Research.
[19] Zhe-shan Quan,et al. Synthesis and anticonvulsant activity of 7-alkoxyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolines. , 2005, Bioorganic & medicinal chemistry letters.
[20] T. Strine,et al. Psychological Distress, Comorbidities, and Health Behaviors among U.S. Adults with Seizures: Results from the 2002 National Health Interview Survey , 2005, Epilepsia.
[21] H. White. Preclinical Development of Antiepileptic Drugs: Past, Present, and Future Directions , 2003, Epilepsia.
[22] J. Gálvez,et al. Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity. , 2003, Bioorganic & medicinal chemistry letters.
[23] Anne Hersey,et al. Rate-Limited Steps of Human Oral Absorption and QSAR Studies , 2002, Pharmaceutical Research.
[24] G. Estiu,et al. Pharmacophore model for antiepileptic drugs acting on sodium channels , 2001 .
[25] E Estrada,et al. In silico studies for the rational discovery of anticonvulsant compounds. , 2000, Bioorganic & medicinal chemistry.
[26] P. Selzer,et al. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.
[27] Michał J. Markuszewski,et al. Brain/blood distribution described by a combination of partition coefficient and molecular mass , 1996 .
[28] R. D. Lynch,et al. Structure, function, and regulation of cellular tight junctions. , 1992, The American journal of physiology.
[29] L. Merlini,et al. Synthesis and anticonvulsant and sedative-hypnotic activity of 4-(alkylimino)-2,3-dihydro-4H-1-benzopyrans and -benzothiopyrans. , 1990, Journal of medicinal chemistry.
[30] H. Nagaya,et al. The role of the nigrotegmental GABAergic pathway in the propagation of pentylenetetrazol-induced seizures , 1989, Brain Research.
[31] W. Löscher,et al. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations , 1988, Epilepsy Research.
[32] Surendra Singh,et al. Synthesis of Some New Thiosemicarbazides, Thiadiazoles, Triazoles and Their Derivatives as Potential Antiviral Agents , 1982, Archiv der Pharmazie.
[33] R. Olsen. GABA‐Benzodiazepine‐Barbiturate Receptor Interactions , 1981, Journal of neurochemistry.
[34] E. Lien,et al. Quantitative structure-activity relationships and dipole moments of anticonvulsants and CNS depressants. , 1979, Journal of pharmaceutical sciences.
[35] J. Penry,et al. Antiepileptic Drug Development: II. Anticonvulsant Drug Screening , 1978, Epilepsia.
[36] J. Barker,et al. Specific antagonism of GABA‐mediated postsynaptic inhibition in cultured mammalian spinal cord neurons , 1978, Neurology.
[37] J. Gaddum,et al. The Pharmacological Basis of Therapeutics , 1966 .
[38] Brahim Tabarki,et al. Antiepileptic drugs , 2014, Reactions Weekly.
[39] M. Bialer,et al. Valproic acid: Second generation , 2011, Neurotherapeutics.
[40] S. Lhatoo,et al. CNS Adverse Events Associated with Antiepileptic Drugs , 2008, CNS drugs.
[41] H. Stefan,et al. Novel anticonvulsant drugs. , 2007, Pharmacology & therapeutics.
[42] E. Donner,et al. New generation anticonvulsants for the treatment of epilepsy in children , 2006, NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics.
[43] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[44] H. Lankau,et al. Synthesis, anticonvulsant activity, and structure-activity relationships of sodium channel blocking 3-aminopyrroles. , 1998, Journal of medicinal chemistry.
[45] K. Luthman,et al. Correlation of drug absorption with molecular surface properties. , 1996, Journal of pharmaceutical sciences.
[46] K. Gale,et al. GABA and epilepsy: basic concepts from preclinical research. , 1992, Epilepsia.
[47] B. G. White,et al. Antiepileptic Drug Development Program. , 1984, Cleveland Clinic quarterly.
[48] W. Löscher. 3-Mercaptopropionic acid: convulsant properties, effects on enzymes of the gamma-aminobutyrate system in mouse brain and antagonism by certain anticonvulsant drugs, aminooxyacetic acid and gabaculine. , 1979, Biochemical pharmacology.